Form 4: Chemours Director Turner Acquires Shares and Reports Beneficial Ownership Changes
SEC Form 4 Filing
Director Leslie M Turner reports acquisition of Chemours Co common stock and updates to beneficial ownership.
Summary
- On April 22, 2025, Leslie M Turner, a director of Chemours Co, reported a transaction involving the company's common stock.
- Turner acquired 14,096 shares of common stock.
- Following the reported transaction, Turner beneficially owns 16,982 shares of Chemours Co.
- The acquired shares include stock units that convert one-for-one to Chemours common stock upon separation from service on the board, as well as dividend equivalent units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as this is a standard regulatory filing detailing a director's stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Positives
- The director's acquisition of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in insider trading activities, providing investors with insights into the actions of company directors and officers.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 04/22/2025 | Date of transaction involving Chemours Co common stock. |
| 04/24/2025 | Date of signature for the Form 4 filing. |
Keywords
Chemours, Director, Beneficial Ownership, Stock Acquisition, Form 4, Turner, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.